Literature DB >> 21952501

Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.

Liana G Apostolova1, Kristy S Hwang, Luis D Medina, Amity E Green, Meredith N Braskie, Rebecca A Dutton, Jeffrey Lai, Daniel H Geschwind, Jeffrey L Cummings, Paul M Thompson, John M Ringman.   

Abstract

BACKGROUND: Both familial and sporadic Alzheimer's disease (AD) result in progressive cortical and subcortical atrophy. Familial autosomal dominant AD (FAD) allows us to study AD brain changes presymptomatically.
METHODS: 33 subjects at risk for FAD (25 for PSEN1 and 8 for APP mutations; 22 mutation carriers and 11 controls) and 3 demented PSEN1 mutation carriers underwent T(1)-weighted MPRAGE 1.5T MRI. Using the hippocampal radial distance and cortical pattern matching techniques, we investigated the effects of carrier status and dementia diagnosis on cortical and hippocampal atrophy. All analyses were corrected for age and relative age (years to median age of disease onset in the family).
RESULTS: The dementia cases had pronounced cortical atrophy in the lateral and medial parietal, posterior cingulate and frontal cortices and hippocampal atrophy bilaterally relative to both nondemented carriers and controls. Nondemented carriers did not show significant cortical thinning or hippocampal atrophy relative to controls.
CONCLUSIONS: FAD is associated with thinning of the posterior association and frontal cortices and hippocampal atrophy. Larger sample sizes may be necessary to reliably identify cortical atrophy in presymptomatic carriers.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21952501      PMCID: PMC3222115          DOI: 10.1159/000330471

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  33 in total

1.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

2.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

Authors:  N C Fox; E K Warrington; P A Freeborough; P Hartikainen; A M Kennedy; J M Stevens; M N Rossor
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

Review 3.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

Review 4.  Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia.

Authors:  Paul M Thompson; Kiralee M Hayashi; Elizabeth R Sowell; Nitin Gogtay; Jay N Giedd; Judith L Rapoport; Greig I de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David M Doddrell; Yalin Wang; Theo G M van Erp; Tyrone D Cannon; Arthur W Toga
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

5.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

6.  Dynamics of gray matter loss in Alzheimer's disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Mapping hippocampal and ventricular change in Alzheimer disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig I De Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; Michael S Hong; David H Herman; David Gravano; David M Doddrell; Arthur W Toga
Journal:  Neuroimage       Date:  2004-08       Impact factor: 6.556

8.  Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.

Authors:  G B Karas; P Scheltens; S A R B Rombouts; P J Visser; R A van Schijndel; N C Fox; F Barkhof
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

9.  Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Authors:  J C Janssen; J A Beck; T A Campbell; A Dickinson; N C Fox; R J Harvey; H Houlden; M N Rossor; J Collinge
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  15 in total

Review 1.  Future Directions in Imaging Neurodegeneration.

Authors:  Joseph C Masdeu
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

2.  Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.

Authors:  John M Ringman; Giovanni Coppola; David Elashoff; Yaneth Rodriguez-Agudelo; Luis D Medina; Karen Gylys; Jeffrey L Cummings; Greg M Cole
Journal:  Dement Geriatr Cogn Disord       Date:  2012-02-13       Impact factor: 2.959

3.  The value of whole-brain CT perfusion imaging and CT angiography using a 320-slice CT scanner in the diagnosis of MCI and AD patients.

Authors:  Bo Zhang; Guo-Jun Gu; Hong Jiang; Yi Guo; Xing Shen; Bo Li; Wei Zhang
Journal:  Eur Radiol       Date:  2017-06-02       Impact factor: 5.315

4.  Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.

Authors:  Grace J Lee; Po H Lu; Luis D Medina; Yaneth Rodriguez-Agudelo; Stephanie Melchor; Giovanni Coppola; Meredith N Braskie; Xue Hua; Liana G Apostolova; Alex D Leow; Paul M Thompson; John M Ringman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-20       Impact factor: 10.154

5.  Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.

Authors:  Yakeel T Quiroz; Chantal E Stern; Eric M Reiman; Michael Brickhouse; Adriana Ruiz; Reisa A Sperling; Francisco Lopera; Bradford C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-07       Impact factor: 10.154

6.  Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers.

Authors:  Jessica R Petok; Catherine E Myers; Judy Pa; Zachary Hobel; David M Wharton; Luis D Medina; Maria Casado; Giovanni Coppola; Mark A Gluck; John M Ringman
Journal:  Neurobiol Aging       Date:  2018-02-08       Impact factor: 5.133

Review 7.  Neuroimaging in aging and neurologic diseases.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Handb Clin Neurol       Date:  2019

Review 8.  Clinical, biological, and imaging features of monogenic Alzheimer's Disease.

Authors:  Andrea Pilotto; Alessandro Padovani; Barbara Borroni
Journal:  Biomed Res Int       Date:  2013-11-27       Impact factor: 3.411

9.  The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.

Authors:  David M Cash; Gerard R Ridgway; Yuying Liang; Natalie S Ryan; Kirsi M Kinnunen; Thomas Yeatman; Ian B Malone; Tammie L S Benzinger; Clifford R Jack; Paul M Thompson; Bernardino F Ghetti; Andrew J Saykin; Colin L Masters; John M Ringman; Stephen P Salloway; Peter R Schofield; Reisa A Sperling; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; Randall J Bateman; John C Morris; Martin N Rossor; Sébastien Ourselin; Nick C Fox
Journal:  Neurology       Date:  2013-09-18       Impact factor: 9.910

10.  Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Authors:  Tammie L S Benzinger; Tyler Blazey; Clifford R Jack; Robert A Koeppe; Yi Su; Chengjie Xiong; Marcus E Raichle; Abraham Z Snyder; Beau M Ances; Randall J Bateman; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Paul S Aisen; Jon J Christensen; Lindsay Ercole; Russ C Hornbeck; Angela M Farrar; Patricia Aldea; Mateusz S Jasielec; Christopher J Owen; Xianyun Xie; Richard Mayeux; Adam Brickman; Eric McDade; William Klunk; Chester A Mathis; John Ringman; Paul M Thompson; Bernardino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Stephen Salloway; Stephen Correia; Peter R Schofield; Colin L Masters; Christopher Rowe; Victor L Villemagne; Ralph Martins; Sebastien Ourselin; Martin N Rossor; Nick C Fox; David M Cash; Michael W Weiner; David M Holtzman; Virginia D Buckles; Krista Moulder; John C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.